The role of CT in detecting AF substrate.
AF ablation
AF substrate
Atrial fibrillation
Journal
Trends in cardiovascular medicine
ISSN: 1873-2615
Titre abrégé: Trends Cardiovasc Med
Pays: United States
ID NLM: 9108337
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
received:
08
08
2020
revised:
29
09
2020
accepted:
10
10
2020
pubmed:
18
10
2020
medline:
11
3
2022
entrez:
17
10
2020
Statut:
ppublish
Résumé
Despite technological advancements and evolving ablation strategies, atrial fibrillation catheter ablation outcome remains suboptimal for a cohort of patients. Imaging-based biomarkers have the potential to play a pivotal role in the overall assessment and prognostic stratification of AF patients, allowing for tailored treatments and individualized care. Alongside consolidated evaluation parameters, novel imaging biomarkers that can detect and stage the remodelling process and correlate it to electrophysiological phenomena are emerging. This review aims to provide a better understanding of the different types of atrial substrate, and how Computed Tomography can be used as a pre-ablation risk stratification tool by assessing the various novel imaging biomarkers, providing a valuable insight into the mechanisms that sustain AF and potentially allowing for a patient-specific ablation strategy.
Identifiants
pubmed: 33068722
pii: S1050-1738(20)30127-4
doi: 10.1016/j.tcm.2020.10.004
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
457-466Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2020. Published by Elsevier Inc.